After a Covidshield Coronavirus vaccine trial participant claimed that he suffered from a virtual neurological breakdown after being administered a dose, The Serum Institute of India has reacted sharply, dismissing the allegations as malicious and misconceived. It has said that it will file a Rs.100 Crore defamation suit against the Participant. Serum Institute has said that while it sympathised with the volunteer's medical condition there was absolutely no correlation with the vaccine trial and the medical condition of the volunteer.

#SerumInstituteOfIndia #CovidshieldVaccine #Coronavirus